| 3.28 0.13 (4.13%) | 09-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 4.49 | 1-year : | 5.25 |
| Resists | First : | 3.84 | Second : | 4.49 |
| Pivot price | 2.87  |
|||
| Supports | First : | 2.87 | Second : | 2.26 |
| MAs | MA(5) : | 3.12 |
MA(20) : | 2.93 |
| MA(100) : | 2.33 |
MA(250) : | 2.68 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 64.6 |
D(3) : | 57.1 |
| RSI | RSI(14): 60.1 |
|||
| 52-week | High : | 4.9 | Low : | 1.52 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MGRM ] has closed below upper band by 20.7%. Bollinger Bands are 84.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 16 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 3.43 - 3.45 | 3.45 - 3.46 |
| Low: | 3.07 - 3.08 | 3.08 - 3.09 |
| Close: | 3.25 - 3.28 | 3.28 - 3.3 |
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Thu, 29 Aug 2024
Monogram Orthopedics (NASDAQ: MGRM) Readies Commercialization Of Next-Gen Surgical Robot - Nasdaq
Thu, 29 Aug 2024
Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Update - MarketBeat
Mon, 12 Aug 2024
Monogram Orthopaedics Announces Strategic Collaboration with Shalby - TipRanks
Thu, 11 Jul 2024
MGRM - Monogram Technologies Inc. Latest Stock News & Market Updates - StockTitan
Wed, 15 May 2024
Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies - Raleigh News & Observer
Mon, 13 May 2024
Monogram Engages Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S. - Kansas City Star
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 32 (M) |
| Held by Insiders | 2.232e+007 (%) |
| Held by Institutions | 37 (%) |
| Shares Short | 233 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.446e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -4 % |
| Return on Assets (ttm) | 76 % |
| Return on Equity (ttm) | -61 % |
| Qtrly Rev. Growth | 365000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.52 |
| Qtrly Earnings Growth | -0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 342890 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|